The angiopoietins and Tie receptors are involved in blood vessel formation. The role of the angiopoietin/Tie receptor system in myocardial ischaemia/reperfusion is not well known. To investigate the participation of angiopoietins and Tie receptors in myocardial ischaemia/reperfusion, adult Wistar rats were studied in which the left coronary artery was ligated for 30 min, followed by reperfusion. Angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), Tie1 and Tie2 were measured immediately after relief of occlusion, and 1, 6, 24 and 72 h after reperfusion, by Northern blot, Western blot and immunohistochemical staining. Ang2 mRNA was increased significantly at 24 h and 48 h after reperfusion, and returned to baseline levels at 72 h, in the jeopardized myocardium. Tie2 mRNA increased 3.4-fold immediately after the relief of occlusion, reached a maximum 8-fold increase at 24 h after reperfusion and remained elevated up to 72 h. Ang2 protein levels also increased after reperfusion, reaching a maximum 2.2-fold increase at 48 h after reperfusion. Tie2 protein increased immediately after relief of ischaemia, and showed a significant increase from 6 h to 72 h after reperfusion as compared with the sham control. Ang1 and Tie1 mRNA and protein did not show significant changes after ischaemia/reperfusion. Immunohistochemical studies also showed increased immunoreactivity of Ang2 and Tie2 in the jeopardized myocardium after ischaemia/reperfusion. In conclusion, expression of both Ang2 and Tie2 increased after ischaemia/reperfusion in the rat ventricular myocardium, while the expression of Ang1 and Tie1 did not.
INTRODUCTION
Blood vessel development and remodelling are regulated by receptor tyrosine kinases and their ligands [1, 2] . Targeted disruption of the endothelial-cell-selective receptor tyrosine kinases vascular endothelial growth factor (VEGF)-R1 [3] , VEGF-R2 [4] , Tie1 [5] and Tie2 [6] leads in each case to embryonic lethality with severely defective vasculature. Angiopoietin-1 (Ang1) was first identified to be a secreted ligand for the Tie2 receptor in 1996 by Davis et al. [7] . Subsequently, angiopoietin-2 (Ang2) was identified as a relative of Ang1 by homology screening, and was shown to bind, but not cause phosphorylation of, the Tie2 receptor [8] . When expressed constitutively in transgenic mice, Ang2 was demonstrated to antagonize the effects of Ang1, leading to disruption of angiogenesis in vivo [9] . Tie2 and the angiopoietins are expressed later in development than the VEGF receptors and their respective ligands [10] , and the expression of Ang1 appears to become more widespread as development proceeds [8] .
Although Ang1 is not mitogenic for endothelial cells, it can induce endothelial cell sprouting [11, 12] and inhibit endothelial cell apoptosis [13] [14] [15] . Ang1 can also protect the adult vasculature against plasma leakage [16] . Hypoxia [17, 18] and cytokines such as tumour necrosis factor-α [19] up-regulate Ang2 expression in endothelial cells. Tie2 receptor expression is also stimulated by hypoxia and pro-inflammatory cytokines in endothelial cells [20] . Tie2 is broadly expressed in the endothelium of the quiescent adult vasculature [21] . Moreover, Tie2 is tyrosine-phosphorylated in both angiogenic tissues and quiescent adult tissues. Tie2 signalling may have a dual function in both vascular growth and vascular maintenance. Witzenbichler et al. [22] demonstrated that Tie2 as well as Ang1 were expressed in normal human arteries and veins. This finding suggests that the role of angiopoietin/Tie2 may extend beyond embryonic angiogenesis to maintaining the integrity of the adult vasculature.
Experimental models and studies have shown that hypoxia/ischaemia induces vascular proliferation in the ischaemic myocardium [23, 24] . Hypoxia/ischaemiainduced angiogenesis is a tightly controlled multistep process by which new blood vessels are formed by sprouting from the pre-existing vasculature [25] . The expression and regulation of angiopoietins and Tie receptors may be critical in the balance between physiological and pathological angiogenesis. Angiogenesis occurs in the ischaemic myocardium. However, the expression of angiopoietins/Tie receptors during ischaemia/reperfusion of the myocardium is not well known [26] . The purpose of the present study was to investigate the role of the angiopoietin/Tie receptor system in myocardial ischaemia/reperfusion. Information about angiopoietin/Tie receptor expression during myocardial ischaemia/reperfusion may lead to meaningful new therapies for myocardial ischaemic injuries.
METHODS

Rat model of acute myocardial ischaemia and reperfusion
A rat model of left anterior descending coronary artery (LAD) occlusion and reperfusion was used, employing Wistar rats weighing 250-300 g. All protocols were approved by our institutional animal care and use committee.
After induction of anaesthesia (pentobarbital; 40 mg/ kg intraperitoneally), a tracheotomy was performed, and the animal was ventilated on a Harvard Rodent Respirator. A reversible coronary artery snare occluder was placed around the proximal LAD through a midline sternotomy. Sham-operated control animals were prepared in a similar manner, except that the LAD was not occluded. After 30 min of LAD occlusion, the occluder was removed and restoration of blood flow was verified. After the ischaemic insult, the wound was closed and the tracheotomy was closed so that spontaneous respiration occurred. At the end of experiment (30 min after the onset of ischaemia, or 1, 6, 24, 48 or 72 h after reperfusion), rats were killed by decapitation under anaesthesia, and the heart was quickly removed and stored in liquid nitrogen.
RNA isolation and reverse transcription (RT)
Total RNA was isolated from the frozen left ventricle using the single-step acid guanidinium thiocyanate/ phenol/chloroform extraction method [27] . Total RNA • C for 7 min, then repeat cycles of 94
• C for 45 s, 55
• C for 45 s and 72
• C for 7 min, and finally cooled to 4
• C. PCR products were run on a 2 % (w/v) agarose gel for DNA fragment size verification; they were then eluted and used as probes to detect the respective mRNAs in Northern blot analysis.
Northern blot analysis
RNA samples (20 µg/lane) were applied to a 1.2 % (w/v) agarose gel in the presence of 2.2 mol/l formaldehyde. After electrophoresis, gels were transblotted on to Nytran membranes. Membranes were prehybridized at 60
• C in a solution containing 1 % SDS, 1 mol/l NaCl, 10 % dextran sulphate and 100 µg/ml sheared salmon sperm DNA. RT-PCR-amplified cDNA probes were labelled with [ 32 P]dCTP using the random primer labelling method. Radioactive probes were added directly to the pre-hybridization solution. Following overnight hybridization at 60
• C, membranes were washed twice in 2 × SSC (1 × SSC is 0.15 M NaCl/0.015 M sodium citrate) at room temperature for 5 min each, followed by two 30-min washes at 60
• C in 2 × SSC/1 % SDS and two 30-min washes at 60
• C in 0.1 × SSC. Membranes were then exposed to Kodak film. The radioactive bands were quantified by a densitometer.
Western blot analysis
Tissue samples were homogenized in modified RIPA buffer [50 mmol/l Tris (pH 7.4), 1 % IGEPAL CA-630 (Sigma), 0.25 % sodium deoxycholate, 150 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l PMSF and 1 µg/ml of each of aprotinin, leupeptin and pepstatin]. Protein samples were mixed with sample buffer, boiled for 10 min, separated by SDS/PAGE under denaturing conditions, and electroblotted to nitrocellulose membranes. The blots were incubated overnight in Tris-buffered saline containing 5 % (w/v) milk to block non-specific binding of the antibody. Proteins of interest were revealed with specific antibodies (goat polyclonal anti-Ang1 and antiAng2 antibodies, and rabbit polyclonal anti-Tie1 and anti-Tie2 antibodies; all from Santa Cruz Biotechnology Inc.) as indicated (1:1000 dilution) for 1 h at room temperature, followed by incubation with a 1:5000 dilution of horseradish peroxidase-conjugated polyclonal anti-rabbit antibody for 1 h at room temperature. Signals were visualized by chemiluminescent detection. Equal protein loading of the samples was further verified by staining with a monoclonal antibody against GAPDH. All Western blots were quantified using densitometry. 
Immunohistochemistry
anti-Tie2 antibodies) at a 1:100 dilution for 2 h at room temperature, biotinylated rabbit anti-mouse IgG at 1:400 for 30 min, and Vector Elite ABC biotin-avidinperoxidase complex for 30 min. Sections were then developed with diaminobenzidine and diaminobenzidine enhancer (Vector), counterstained with haematoxylin, and mounted.
Statistical analysis
All results were expressed as means + − S.E.M. Statistical significance was evaluated by ANOVA followed by Turkey-Kramer multiple comparison tests. Analyses were performed with GraphPad software (GraphPad Software Inc., San Diego, CA, U.S.A.). A value of P < 0.05 was considered to denote statistical significance.
RESULTS
Expression of mRNAs in left ventricle
A total of 35 hearts were used for the Northern blot analysis (n = 5 for each time point). The left ventricle was dissected to the left ventricular free wall and the ventricular septum for detection of mRNA levels in 
hypoxia (0 h) and at various periods of time after reperfusion
Sham-operated control animals were prepared in a similar manner as the rats subjected to ischaemia/reperfusion, except that the LAD was not occluded (see the Methods section). Equal RNA loading of the sample was verified by hybridization with a GAPDH probe.
Figure 2 Quantitative analysis of Ang1, Ang2, Tie1 and Tie2 mRNAs in the jeopardized myocardium after 30 min of hypoxia and at various periods of time after reperfusion
Values are means + − S.E.M.; n = 5 in each group. Significance of differences: + P < 0.05 *P < 0.001, compared with sham control.
both the jeopardized and the normal myocardium. The number of animals used in the study is sufficient to reach statistical significance because of the small mean of the error.
After ligation of the LAD followed by reperfusion, Ang2 mRNA levels in the jeopardized myocardium were significantly increased at both 24 h (P < 0.05 compared with sham control) and 48 h (P < 0.001) after reperfusion, and had returned to baseline at 72 h (Figures 1  and 2 ).
The increase in mRNA expression was most obvious for Tie2. Tie2 mRNA increased significantly by 3.4-fold immediately after the relief of occlusion (P < 0.001), reached a maximum 8-fold increase at 24 h after reperfusion and maintained this high level up to 72 h. The myocardial tissue that was not subjected to hypoxia was dissected from the interventricular septum.
Although Ang1 mRNA tended to increase after reperfusion, statistical significance was not reached. The Tie1 mRNA level in the jeopardized myocardium was similar in the control and treated groups. The expression of Ang1, Ang2, Tie1, and Tie2 mRNAs in the normal myocardium was similar in the sham control and treated groups (Figure 3 ).
Western blot analysis after hypoxia/reperfusion
A total of 28 hearts were used for Western blot analysis (n = 4 at each time point). Ang1, Ang2, Tie1 and Tie2 proteins were present in the ventricular myocardium Sham-operated control animals were prepared in a similar manner as the rats subjected to ischaemia/reperfusion, except that the LAD was not occluded (see the Methods section). Equal protein loading of the samples was verified by staining with a GAPDH-specific monoclonal antibody.
at baseline. Hearts obtained from rats subjected to ischaemia displayed a trend for Ang1 protein to increase after reperfusion, although statistical significance was not reached (Figures 4 and 5) . Ang2 protein increased after reperfusion, and reached a maximum of a 2.2-fold increase at 48 h after reperfusion (P < 0.01 compared with sham control). Ang2 protein had declined to almost the preischaemia level at 72 h after reperfusion. Tie1 protein was virtually unaffected by ischaemia/reperfusion, although it was more abundant under baseline conditions than Ang1, Ang2 and Tie2 proteins. The Tie2 protein level increased immediately after relief of ischaemia, and was significantly increased from 6 h (P < 0.05) to 72 h (P < 0.001) after reperfusion as compared with the sham control.
High-level expression of Ang2 and Tie2 in the myocardium
Immunohistochemical staining confirmed the findings from Northern and Western blots. Ang2 and Tie2 antigens were readily detected in jeopardized myocardium after ischaemia of 30 min followed by reperfusion. The intensity of Ang2 and Tie2 immunoreactivity was observed to be greatest at 48 h after reperfusion ( Figure 6 ). The immunoreactivity of Ang2 and Tie2 in the surrounding myocardium that was not ischaemic was similar to that in the control myocardium. The immunoreactivity of Ang1 and Tie1 in the myocardium after ischaemia/reperfusion was similar to the basal distribution patterns. The values were obtained from four independent experiments and were normalized to GAPDH (n = 4 in each group). Significance of differences: *P < 0.05, + P < 0.01, **P < 0.001 compared with sham control.
DISCUSSION
Ischaemic heart injury is a consequence of a marked decrease in the blood supply to the affected region. The resultant low tissue oxygen tension often leads to compensatory neoangiogenesis in order to meet metabolic demands. In the present study, we demonstrated that levels of Ang2 and Tie2 increased specifically in the jeopardized rat myocardium after ischaemia/reperfusion. In contrast, levels of Ang1 and Tie1 were not changed significantly in this model of ischaemia/reperfusion. Expression was confirmed by Northern blot, Western
Figure 6 Immunohistochemical staining of the jeopardized myocardium
Significantly increased immunoreactive signals for Ang2 and Tie2, but not for Tie1, were observed at 48 h after ischaemia/reperfusion. The negative control (NC) comprises jeopardized myocardium stained with haematoxylin, but not incubated with antibodies against Ang2, Tie1 or Tie2.
blot and immunohistochemistry. Changes in Ang2 and Tie2 protein levels were paralleled by changes in mRNA expression. The increases in Ang2 and Tie2 after ischaemia/reperfusion were statistically significant. Because up-regulation of Ang2 and Tie2 proteins occurred before their mRNA levels were significantly affected, it is possible that the in vivo regulation of Ang2 and Tie2 expression during ischaemia/reperfusion is a complex process involving protein synthesis and/or stability. The changes in expression of Ang2 and Tie2 have a temporal and spatial pattern.
The angiopoietin/Tie system plays critical roles in embryonic vascular development and maintenance of the normal adult vasculature [5, 8, 28] . Our study suggests a role for the angiopoietin/Tie system in the response to myocardial ischaemia/reperfusion. Although poorly understood, the development of collateral capillaries and new vessel formation are important processes, which are likely to ameliorate the effects of hypoxia/ischaemia and restore nutritive perfusion. Lobov et al. [29] have shown that Ang2 can stimulate angiogenesis in the presence of VEGF. Myocardial ischaemia is associated with a 7-fold increase in VEGF expression [23, 24] , and enhanced VEGF expression persists in the chronically ischaemic myocardium [30] . Angiogenesis requires co-ordinated signalling events among a variety of endothelial cell growth factors and their receptors. Together with VEGF, the Ang2/Tie2 family induced by ischaemia/reperfusion may be considered to exert a pivotal role in the formation of new functional and stable capillaries.
Ray et al. [26] used variable periods of ischaemia followed by reperfusion for 24 h to elicit changes in the levels of VEGF, angiopoietins and Tie receptors in the rat myocardium. Our present study involved a 30 min period of ischaemia and variable periods of reperfusion. In fact, our results demonstrated that levels of Ang2 and Tie2 increased gradually after reperfusion, which was in contrast with the finding of Ray et al. [26] , who demonstrated a progressive decrease in Ang2 expression after a prolonged period of ischaemia. Our study demonstrated maximal increases in Ang2 and Tie2 levels at 24-48 h after reperfusion. Willam et al. [20] also found that Tie2 expression was increased in rat infarct myocardial tissue. In a focal cerebral ischaemia/reperfusion rat model, a biphasic rise in Ang2 mRNA occurred within 24 h and 2 weeks after ischaemia, whereas Ang1 mRNA rose significantly only after 1 week of ischaemia [31] . The expression of Tie1 and Tie2 mRNAs also increased, starting 24 h after cerebral reperfusion and remaining elevated for up to 2 weeks after ischaemia [31] . Tie1 and Tie2 proteins exhibited a biphasic pattern after cerebral ischaemia/reperfusion [32] . These findings imply that angiopoietin/Tie systems in the heart and brain might respond differently to ischaemia/reperfusion. In addition to the temporal relationship of angiopoietin/Tie expression, we also investigated the spatial relationship in the same model. There were no changes in Ang1, Ang2, Tie1 or Tie2 expression outside the ischaemic region. Therefore the increases in Ang2 and Tie2 expression in the jeopardized myocardium were directly related to ischaemia/reperfusion.
Potential interactions between the Ang2/Tie2 and the VEGF pathways have to be considered. Although Ang1 and Ang2 are not directly mitogenic, both augment the formation of neovessels when administered together with VEGF [33] . Hypoxia induces VEGF expression in the ischaemic myocardium [34] . Recent studies have shown that treatment with Ang2 under particular conditions could stimulate Tie2 autophosphorylation and promote endothelial cell survival [35, 36] . Ang2 is presumed to destabilize blood vessels by interfering with the Ang1/Tie2 signals and with endothelialperiendothelial cell interactions [37] . Thus the expression of Ang2 and VEGF during the same period of myocardial ischaemia/reperfusion may provide a drive for sprouting angiogenesis. Ang2 is a ligand for the Tie2 receptor, and both Ang2 and Tie2 were induced by ischaemia/reperfusion. This may augment the Ang2/Tie2 signal pathway, which can then interact with VEGF to increase myocardial perfusion in order to compensate for myocardial hypoxia or ischaemia.
